171 related articles for article (PubMed ID: 20823145)
1. "Contextual" synthetic lethality and/or loss of heterozygosity: tumor hypoxia and modification of DNA repair.
Chan N; Bristow RG
Clin Cancer Res; 2010 Sep; 16(18):4553-60. PubMed ID: 20823145
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
[TBL] [Abstract][Full Text] [Related]
3. Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts.
Wirthner R; Wrann S; Balamurugan K; Wenger RH; Stiehl DP
Carcinogenesis; 2008 Dec; 29(12):2306-16. PubMed ID: 18842680
[TBL] [Abstract][Full Text] [Related]
4. Regulation of DNA repair in hypoxic cancer cells.
Bindra RS; Crosby ME; Glazer PM
Cancer Metastasis Rev; 2007 Jun; 26(2):249-60. PubMed ID: 17415527
[TBL] [Abstract][Full Text] [Related]
5. Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil?
El-Awady RA; Saleh EM; Dahm-Daphi J
Anticancer Drugs; 2010 Mar; 21(3):277-87. PubMed ID: 20075715
[TBL] [Abstract][Full Text] [Related]
6. A concise review of DNA damage checkpoints and repair in mammalian cells.
Houtgraaf JH; Versmissen J; van der Giessen WJ
Cardiovasc Revasc Med; 2006; 7(3):165-72. PubMed ID: 16945824
[TBL] [Abstract][Full Text] [Related]
7. DNA repair alterations in common pediatric malignancies.
Papaefthymiou MA; Giaginis CT; Theocharis SE
Med Sci Monit; 2008 Jan; 14(1):RA8-15. PubMed ID: 18160950
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.
Luoto KR; Meng AX; Wasylishen AR; Zhao H; Coackley CL; Penn LZ; Bristow RG
Cancer Res; 2010 Nov; 70(21):8748-59. PubMed ID: 20940401
[TBL] [Abstract][Full Text] [Related]
9. The role of DNA repair in benzene-induced carcinogenesis.
Hartwig A
Chem Biol Interact; 2010 Mar; 184(1-2):269-72. PubMed ID: 20056111
[TBL] [Abstract][Full Text] [Related]
10. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
Honma M
Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360
[TBL] [Abstract][Full Text] [Related]
11. Long duration exposure to cadmium leads to increased cell survival, decreased DNA repair capacity, and genomic instability in mouse testicular Leydig cells.
Singh KP; Kumari R; Pevey C; Jackson D; DuMond JW
Cancer Lett; 2009 Jun; 279(1):84-92. PubMed ID: 19232459
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.
Bolderson E; Richard DJ; Zhou BB; Khanna KK
Clin Cancer Res; 2009 Oct; 15(20):6314-20. PubMed ID: 19808869
[TBL] [Abstract][Full Text] [Related]
13. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).
Fedier A; Fink D
Int J Oncol; 2004 Apr; 24(4):1039-47. PubMed ID: 15010846
[TBL] [Abstract][Full Text] [Related]
14. Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines.
Jacob S; Miquel C; Sarasin A; Praz F
Nucleic Acids Res; 2005; 33(1):106-13. PubMed ID: 15642697
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
16. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins.
Bellacosa A
Cell Death Differ; 2001 Nov; 8(11):1076-92. PubMed ID: 11687886
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cell death in the tumor microenvironment.
Wouters BG; Koritzinsky M; Chiu RK; Theys J; Buijsen J; Lambin P
Semin Radiat Oncol; 2003 Jan; 13(1):31-41. PubMed ID: 12520462
[TBL] [Abstract][Full Text] [Related]
19. [DNA repair as a determinant of tumour chemosensitivity].
Oda S; Kuraoka I; Maehara Y
Gan To Kagaku Ryoho; 2007 Mar; 34(3):347-57. PubMed ID: 17353624
[TBL] [Abstract][Full Text] [Related]
20. Shaping of tumor and drug-resistant genomes by instability and selection.
Snijders AM; Fridlyand J; Mans DA; Segraves R; Jain AN; Pinkel D; Albertson DG
Oncogene; 2003 Jul; 22(28):4370-9. PubMed ID: 12853973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
